CD133-positive cells from primary non-small cell lung cancer (NSCLC) specimens exhibited higher levels of genes associated with stemness, migration, and drug efflux than CD133-negative cells (19). This evidence concerns the gene PROM1 and non-small cell lung carcinoma.